Trial Profile
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 08 Mar 2024
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 01 Mar 2024 Planned End Date changed from 1 Jul 2024 to 31 Dec 2024.
- 01 Mar 2024 Planned primary completion date changed from 1 Jan 2024 to 1 Jul 2024.
- 25 Aug 2023 Planned End Date changed from 31 Dec 2023 to 1 Jul 2024.